Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 122,900 shares at $161.00 ($81K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Open-market sale of $80k SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 122,400 | $0 | 0.0% |
| 2 | $161.00 | 500 | $81K | 100.0% |
| Total | $0.66 avg | 122,900 | $81K | 100% |
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |